Found: 41
Select item for more details and to access through your institution.
AUC-Based Monitoring of Vancomycin: Closing the Therapeutic Window.
- Published in:
- Journal of Applied Laboratory Medicine, 2019, p. 743, doi. 10.1373/jalm.2018.027391
- By:
- Publication type:
- Article
Pharmacokinetic/pharmacodynamic predictions and clinical outcomes of patients with augmented renal clearance and Pseudomonas aeruginosa bacteremia and/or pneumonia treated with extended infusion cefepime versus extended infusion piperacillin/tazobactam.
- Published in:
- International Journal of Critical Illness & Injury Science, 2019, v. 9, n. 3, p. 138, doi. 10.4103/IJCIIS.IJCIIS_70_18
- By:
- Publication type:
- Article
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 516, doi. 10.1093/cid/ciae201
- By:
- Publication type:
- Article
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 11, p. 1585, doi. 10.1093/cid/ciac688
- By:
- Publication type:
- Article
Reply to Davis et al.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosa.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple Hospitals.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 7, p. 1187, doi. 10.1093/cid/ciac074
- By:
- Publication type:
- Article
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 5, p. 660, doi. 10.3390/antibiotics11050660
- By:
- Publication type:
- Article
A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia.
- Published in:
- Antibiotics (2079-6382), 2019, v. 8, n. 1, p. 27, doi. 10.3390/antibiotics8010027
- By:
- Publication type:
- Article
Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials.
- Published in:
- Antibiotics (2079-6382), 2016, v. 5, n. 1, p. 6, doi. 10.3390/antibiotics5010006
- By:
- Publication type:
- Article
The Antimicrobial Stewardship Approach to Combating Clostridium Difficile.
- Published in:
- Antibiotics (2079-6382), 2015, v. 4, n. 2, p. 198, doi. 10.3390/antibiotics4020198
- By:
- Publication type:
- Article
Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant Enterococcus faecium Meningitis and Bacteremia.
- Published in:
- Infectious Disease Reports, 2021, v. 13, n. 3, p. 843, doi. 10.3390/idr13030076
- By:
- Publication type:
- Article
Reply to Dilworth et al.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 11, p. 1957, doi. 10.1093/cid/cix677
- By:
- Publication type:
- Article
An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 2, p. 194, doi. 10.1093/cid/cix315
- By:
- Publication type:
- Article
Hepatitis C Management and the Infectious Diseases Pharmacist.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 7, p. 1201, doi. 10.1093/cid/civ545
- By:
- Publication type:
- Article
Telavancin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S35, doi. 10.1093/cid/civ524
- By:
- Publication type:
- Article
Improving Prescribers to Advance Antimicrobial Stewardship.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 8, p. 1259, doi. 10.1093/cid/civ021
- By:
- Publication type:
- Article
Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2017, v. 16, p. 1, doi. 10.1186/s12941-017-0252-7
- By:
- Publication type:
- Article
Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 5, p. 1, doi. 10.1093/ofid/ofac095
- By:
- Publication type:
- Article
In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz545
- By:
- Publication type:
- Article
2004. Impact of Procalcitonin Roll-out Without Antimicrobial Stewardship Guidance in a Community Hospital Emergency Department.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S672, doi. 10.1093/ofid/ofz360.1684
- By:
- Publication type:
- Article
2269. Clinical Outcomes in Patients with Carbapenem-Non-Susceptible, β-Lactam-Susceptible Pseudomonas aeruginosa Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S776, doi. 10.1093/ofid/ofz360.1947
- By:
- Publication type:
- Article
Association Between Estimated Pharmacokinetic/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1093/ofid/ofz400
- By:
- Publication type:
- Article
Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum].
- Published in:
- Infection & Drug Resistance, 2021, v. 14, p. 595, doi. 10.2147/IDR.S306146
- By:
- Publication type:
- Article
Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.
- Published in:
- Infection & Drug Resistance, 2021, v. 14, p. 125, doi. 10.2147/IDR.S246174
- By:
- Publication type:
- Article
Glutathione-Conjugated Hydrogels: Flexible Vehicles for Personalized Treatment of Bacterial Infections.
- Published in:
- Pharmaceutical Research, 2021, v. 38, n. 7, p. 1247, doi. 10.1007/s11095-021-03057-1
- By:
- Publication type:
- Article
Implementation and optimization of molecular rapid diagnostic tests for bloodstream infections.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 16, p. 1191, doi. 10.2146/ajhp170604
- By:
- Publication type:
- Article
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 3, p. 221, doi. 10.1310/hpj5203-221
- By:
- Publication type:
- Article
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 4, p. 264, doi. 10.1002/phar.2781
- By:
- Publication type:
- Article
BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department.
- Published in:
- Pharmacy, 2019, v. 7, n. 4, p. 145, doi. 10.3390/pharmacy7040145
- By:
- Publication type:
- Article
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 6, p. 1445, doi. 10.1007/s40121-023-00815-z
- By:
- Publication type:
- Article
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 769, doi. 10.1007/s40121-020-00344-z
- By:
- Publication type:
- Article
Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections.
- Published in:
- Infectious Diseases & Therapy, 2017, v. 6, n. 2, p. 149, doi. 10.1007/s40121-017-0149-y
- By:
- Publication type:
- Article
Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 7, p. 1069, doi. 10.1007/s40262-022-01146-x
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 4, p. 539, doi. 10.1007/s40262-021-01086-y
- By:
- Publication type:
- Article
The Impact of Body Weight and Renal Function on the Risk of Bleeding With Direct Oral Anticoagulants in Atrial Fibrillation.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 11, p. 1309, doi. 10.1177/1060028021995201
- By:
- Publication type:
- Article
The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative pathogens: A review.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.888079
- By:
- Publication type:
- Article
A randomized, open‐label pharmacokinetic trial of tacrolimus extended‐release dosing in obese de novo kidney transplant recipients.
- Published in:
- Clinical Transplantation, 2019, v. 33, n. 8, p. N.PAG, doi. 10.1111/ctr.13640
- By:
- Publication type:
- Article
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 11, p. 2165, doi. 10.1111/bcp.14308
- By:
- Publication type:
- Article
Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
- Published in:
- 2022
- By:
- Publication type:
- journal article